written on 30.04.2014
pt:
Tags:
,

High fees jeopardize early access scheme

TAGS: ,

The total costs of the UK's newly launched early access to medicines schemes (EAMS), including up to £33,000 in application fees, may be prohibitive for small to medium sized companies, potentially undermining the scheme's proposed purpose of…

Latest Report